B. B. Duman Et Al. , "PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer," JOURNAL OF BUON , vol.18, no.1, pp.44-50, 2013
Duman, B. B. Et Al. 2013. PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer. JOURNAL OF BUON , vol.18, no.1 , 44-50.
Duman, B. B., Sahin, B., Acikalin, A., Ergin, M., & Zorludemir, S., (2013). PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer. JOURNAL OF BUON , vol.18, no.1, 44-50.
Duman, B. Et Al. "PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer," JOURNAL OF BUON , vol.18, no.1, 44-50, 2013
Duman, B. B. Et Al. "PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer." JOURNAL OF BUON , vol.18, no.1, pp.44-50, 2013
Duman, B. B. Et Al. (2013) . "PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer." JOURNAL OF BUON , vol.18, no.1, pp.44-50.
@article{article, author={B. B. Duman Et Al. }, title={PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer}, journal={JOURNAL OF BUON}, year=2013, pages={44-50} }